Hemoglobin θ Inhibitors
Chemical inhibitors of hemoglobin θ can disrupt its function through various biochemical interactions. Hydroxyurea targets the DNA synthesis pathway, reducing the availability of deoxyribonucleotide triphosphates necessary for the formation of hemoglobin θ, while cyanate chemically modifies hemoglobin by reacting with its amino terminal groups, resulting in carbamylated hemoglobin with diminished oxygen-carrying capacity. Malonic acid acts as a competitive inhibitor of enzymes responsible for 2,3-bisphosphoglycerate synthesis, thus increasing hemoglobin's oxygen affinity and impairing oxygen release to tissues. Arsenic trioxide binds to redox-active cysteine residues within hemoglobin θ, leading to conformational changes that compromise its functionality. Similarly, chlorate and sodium nitrite both induce the oxidation of hemoglobin's iron from the ferrous to the ferric state, producing methemoglobin, which is less effective at oxygen transport.
Additional inhibitors, like acetylphenylhydrazine and phenylhydrazine, cause oxidative damage to hemoglobin θ, leading to the denaturation of its globin chains and a subsequent loss of function. Benzene and lead acetate disrupt the heme synthesis pathway, the latter inhibiting key enzymes such as ALA dehydratase and ferrochelatase, resulting in reduced heme availability which is critical for hemoglobin θ's proper assembly and operation. Aluminum chloride interferes with the action of 2,3-BPG on hemoglobin θ by binding to its phosphate groups, thus stabilizing the less oxygen-affine state of hemoglobin and impeding oxygen release. Lastly, bepridil interacts with the lysine residues on hemoglobin θ, potentially altering the protein's conformation necessary for oxygen binding and release, thus hampering its function as an oxygen transporter. Each of these chemicals can interact with hemoglobin θ in a manner that inhibits its natural role in oxygen transport and delivery within the body.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, which is essential for DNA synthesis. This leads to a reduction in deoxyribonucleotide triphosphate (dNTP) levels, which are necessary for hemoglobin synthesis. Hemoglobin θ, being a component of hemoglobin, will be functionally inhibited due to the lack of building blocks for its assembly. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide can bind to the sulfhydryl groups of redox-active cysteine residues in hemoglobin θ, leading to the formation of sulfhydryl-arsenic bonds. This binding can induce conformational changes that impair the hemoglobin's functionality, resulting in its inhibition. | ||||||
Sodium chlorate | 7775-09-9 | sc-212938 | 100 g | $59.00 | 1 | |
Chlorate oxidizes the iron in hemoglobin θ from the ferrous (Fe2+) state to the ferric (Fe3+) state, forming methemoglobin which is incapable of binding oxygen effectively. This oxidation inhibits the ability of hemoglobin θ to transport oxygen, thus functionally inhibiting the protein. | ||||||
Benzene | 71-43-2 | sc-239290 | 1 L | $79.00 | ||
Benzene metabolites can disrupt the heme synthesis pathway by inhibiting enzymes like ALA dehydratase, which is crucial for the production of heme, an integral component of hemoglobin θ. Inhibition of heme synthesis directly leads to the functional inhibition of hemoglobin θ synthesis. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $85.00 | ||
Lead acetate inhibits several enzymes in the heme synthesis pathway, including ALA dehydratase and ferrochelatase. This inhibition leads to decreased heme availability, which is necessary for hemoglobin θ function, thereby functionally inhibiting it by preventing its proper assembly and operation. | ||||||
Sodium nitrite | 7632-00-0 | sc-203393A sc-203393B sc-203393 | 25 g 100 g 500 g | $20.00 $22.00 $41.00 | 1 | |
Sodium nitrite converts hemoglobin to methemoglobin by oxidizing the iron moiety. Hemoglobin θ, when converted to methemoglobin, loses its ability to effectively bind and release oxygen, thereby being functionally inhibited. | ||||||
Phenylhydrazine | 100-63-0 | sc-250701 sc-250701A | 5 g 100 g | $45.00 $52.00 | ||
Phenylhydrazine causes oxidative damage to the heme group of hemoglobin θ and the globin chains, leading to hemolysis and the formation of Heinz bodies. The oxidative damage to the heme group inhibits the normal function of hemoglobin θ as an oxygen transporter. | ||||||
Aluminum chloride anhydrous | 7446-70-0 | sc-214528 sc-214528B sc-214528A | 250 g 500 g 1 kg | $94.00 $99.00 $136.00 | ||
Aluminum chloride binds to the phosphate groups in 2,3-BPG, which stabilizes the T state of hemoglobin and reduces its oxygen affinity. The binding of aluminum to 2,3-BPG can prevent its interaction with hemoglobin θ, thereby inhibiting its ability to release oxygen and effectively inhibiting the protein's function. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Bepridil has been observed to interact with hemoglobin and alter its functionality. It can bind to the Lysine residues on the hemoglobin molecule, including hemoglobin θ, which could interfere with the conformational changes required for oxygen binding and release, thus leading to functional inhibition. | ||||||